866-997-4948(US-Canada Toll Free)

Regenerative Medicine Market (Bone and Joint) (By Technology - Stem Cell Therapy, Biomaterial and Tissue Engineering; By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Published By :

Transparency

Published Date : Jul 2014

Category :

Biotechnology

No. of Pages : 85 Pages

U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital defects, disease and age. Moreover, it has included stem cell therapy, tissue engineering and biomaterial under the umbrella of regenerative medicine. Regenerative medicine has wide areas of application such as cardiovascular, neurology, orthopedic and musculoskeletal diseases and disorders. The global market for regenerative medicine bone and joint application is dominated by various bone graft substitute in 2012. However, it is expected that tissue engineering will become a lucrative market in future. Factors such as growing geriatric population, favorable government support and increasing bone and joint reconstructive surgeries accentuate growth of the global regenerative medicine bone and joint application market. 

This research report explains various advancements occurring in this market and analyzes the global regenerative medicine (bone and joint) market by technology and application. The regenerative medicine bone and joint application market by technology is further segmented into stem cell therapy, biomaterials and tissue engineering. Likewise, on basis of application the global regenerative medicine (bone and joint) market is segmented as bone graft substitutes, osteoarticular diseases, allogenic bones, autogenic bone and others. 

This report includes estimation of the global regenerative medicine (bone and joint) market in terms of value (USD million) for the period 2011 to 2019, considering 2012 as the base year. In addition, current trends and recent developments are taken into consideration while determining the growth rate of the global regenerative medicine (bone and joint) market. The report provides market size and forecast for each segment, sub-segment and geographic region with CAGR % for the period 2013 to 2019.

Geographically, the global regenerative medicine (bone and joint) market has been segmented into four regions: North America, Europe, Asia-Pacific and Rest of the World (RoW). Market size, forecast and CAGR (%) for each region have been provided. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the regenerative medicine (bone and joint) market and future opportunities are provided in the report. A PESTLE analysis has also been done while estimating individual geographies in order to provide current as well as future status. A list of recommendations for existing as well as new entrants has also been discussed in the study that is expected to help in decision-making. 

Major market players profiled in this report includes Anika Therapeutics, Inc., Arthrex, Inc., Baxter International, Inc., CONMED Corporation, DePuy Synthes, Inc., Medtronic, Inc., Smith & Nephew PLC, Stryker Corporation and Zimmer Holdings, Inc. 

The global regenerative medicine (bone and joint) market is segmented as follows:

Regenerative Medicine (Bone and Joint) Market, by Technology
  • Stem Cell Therapy
  • Biomaterial
  • Tissue Engineering
Regenerative Medicine (Bone and Joint) Market, by Application
  • Bone Graft Substitutes
  • Osteoarticular Diseases
  • Allogeneic Bones
  • Autogenic Bones
  • Others
Regenerative Medicine (Bone and Joint) Market, by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
Table of Contents

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Assumptions
1.4 List of Abbreviations

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Regenerative Medicine (Bone and Joint) Market (2012 & 2019) 
2.2 Global Regenerative Medicine (Bone and Joint) Market, by Technology, 2012 (USD Million) 
2.3 Comparative Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2012 and 2019 (Value %)

Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 Technological innovations in biomaterials, stem cell therapy and tissue engineering are fueling the development of regenerative medicine products
3.2.2 Growing prevalence of bone and joint disorders demand the growth of regenerative medicine products
3.2.3 Growing number of orthopedic surgeries fuels the growth of the global regenerative medicine (bone and joint) market
3.3 Restraints
3.3.1 Regulatory constraints pose a threat to the development of regenerative medicine (bone and joint) market
3.3.2 Ethical issues and post implantation infections are hindering overall market growth
3.4 Opportunities
3.4.1 Capitalization on the potential presented by emerging markets in Asia Pacific
3.5 Porter’s Five Force Analysis: Global Regenerative Medicine (Bone and Joint) Market
3.5.1 Bargaining power of suppliers
3.5.2 Bargaining power of buyers
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Competitive rivalry
3.6 Competitive Landscape
3.6.1 Market Share Analysis by Key Players, 2012 (Value %)
3.7 Market Attractiveness Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography

Chapter 4 Regenerative Medicine (Bone and Joint) Market, by Technology
4.1 Introduction
4.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Technology, 2011 – 2019 (USD Million) 
4.2 Stem Cell Therapy
4.2.1 Global Stem Cell Therapy Market Revenue, 2011 – 2019 (USD Million) 
4.3 Biomaterials
4.3.1 Global Biomaterials Market Revenue, 2011 – 2019 (USD Million) 
4.4 Tissue Engineering
4.4.1 Global Tissue Engineering Market Revenue, 2011 – 2019 (USD Million) 

Chapter 5 Regenerative Medicine (Bone and Joint) Market, by Applications
5.1 Overview
5.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Applications, 2011 – 2019 (USD Million) 
5.2 Bone Graft Substitutes
5.2.1 Global Bone Graft Substitute Application Market Revenue, 2011 – 2019 (USD Million) 
5.3 Osteoarticular Diseases
5.3.1 Global Osteoarticular Diseases Application Market Revenue, 2011 – 2019 (USD Million) 
5.4 Allogeneic Bones
5.4.1 Global Allogenic Bones Application Market Revenue, 2011 – 2019 (USD Million) 
5.5 Autogenic Bones
5.5.1 Global Autogenic Bone Application Market Revenue, 2011 – 2019 (USD Million) 
5.6 Others
5.6.1 Global Others Application Market Revenue, 2011 – 2019 (USD Million) 

Chapter 6 Regenerative Medicine (Bone and Joint) Market, by Geography
6.1 Overview
6.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Geography, 2011 – 2019 (USD Million) 
6.2 North America
6.2.1 North America Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 
6.3 Europe
6.3.1 Europe Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 
6.4 Asia-Pacific
6.4.1 Asia-Pacific Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 
6.5 Rest of the World (RoW) 
6.5.1 RoW Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 

Chapter 7 Recommendations
7.1 Market Strategy for Success
7.1.1 Rigorous research and development initiatives for innovative products
7.1.2 Investing in emerging economies
7.2 Barriers and Future Assumptions
7.2.1 Ethical issues pertaining to stem cell therapy hampering market growth

Chapter 8 Company Profiles
8.1 Anika Therapeutics, Inc. 
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 Arthrex, Inc. 
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategies
8.2.5 Recent Developments
8.3 Baxter International, Inc. 
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 CONMED Corporation
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.4.5 Recent Developments
8.5 DePuy Synthes, Inc. 
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Business Strategies
8.5.5 Recent Developments
8.6 Medtronic, Inc. 
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.5 Recent Developments
8.7 Smith & Nephew plc
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategies
8.7.5 Recent Developments
8.8 Stryker Corporation
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.8.5 Recent Developments
8.9 Zimmer Holdings, Inc. 
8.9.1 Business Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.5 Recent Developments

List of Table


TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Regenerative Medicine (Bone and Joint) Market (2012 & 2019) 
TABLE 3 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Technology, 2011 – 2019 (USD Million) 
TABLE 4 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Applications, 2011 – 2019 (USD Million) 
TABLE 5 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Geography, 2011 – 2019 (USD Million) 

List of Chart

FIG. 1 Regenerative Medicine (Bone and Joint): Market Segmentation
FIG. 2 Global Regenerative Medicine (Bone and Joint) Market, by Technology, 2012 (USD Million) 
FIG. 3 Comparative Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2012 & 2019 (Value %)
FIG. 4 Porter’s Five Forces Analysis: Global Regenerative Medicine (Bone and Joint) Market
FIG. 5 Market Share Analysis: Regenerative Medicine (Bone and Joint) Market, 2012 (Value %)
FIG. 6 Market Attractiveness Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2012 Value (%)
FIG. 7 Global Stem Cell Therapy Market Revenue, 2011 – 2019 (USD Million) 
FIG. 8 Global Biomaterials Market Revenue, 2011 – 2019 (USD Million) 
FIG. 9 Global Tissue Engineering Market Revenue, 2011 – 2019 (USD Million) 
FIG. 10 Global Bone Graft Substitute Application Market Revenue, 2011 – 2019 (USD Million) 
FIG. 11 Global Osteoarticular Diseases Application Market Revenue, 2011 – 2019 (USD Million) 
FIG. 12 Global Allogeneic Bones Application Market Revenue, 2011 – 2019 (USD Million) 
FIG. 13 Global Autogenic Bone Application Market Revenue, 2011 – 2019 (USD Million) 
FIG. 14 Global Others Application Market Revenue, 2011 – 2019 (USD Million) 
FIG. 15 North America Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 
FIG. 16 Europe Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 
FIG. 17 Asia-Pacific Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 
FIG. 18 RoW Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 
FIG. 19 Anika Therapeutics, Inc.: Annual Revenue, 2011 – 2013 (USD Million) 
FIG. 20 Baxter International, Inc.: Annual Revenue, 2011 – 2013 (USD Million) 
FIG. 21 Conmed Corporation: Annual Revenue, 2011 – 2013 (USD Million) 
FIG. 22 Johnson & Johnson, Orthopedic Franchise**, Annual Revenue: 2011 – 2013 (USD Million) 
FIG. 23 Medtronic, Inc.: Annual Revenue, 2011 – 2013 (USD Million) 
FIG. 24 Smith & Nephew PLC: Annual Revenue, 2011 – 2013 (USD Million) 
FIG. 25 Stryker Corporation: Annual Revenue, 2011 – 2013 (USD Million) 
FIG. 26 Zimmer Holdings. Inc,: Annual Revenue, 2011 – 2013 (USD Million) 

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *